The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

The US Food and Drug Administration has approved a new nasal spray for depression treatment. Known as Spravato and ...

Since October 2020 – when the Health Sciences Authority (HSA) first authorised sale of an esketamine ... nasal spray Spravato is now a mainstream prescription for treatment-resistant depression ...

Since October 2020 – when the Health Sciences Authority (HSA) first authorized sale of an esketamine ... for Singapore, but Spravato is available at about 2,800 treatment centers worldwide ...

J&J is already a player in the market for drugs to treat resistant MDD with nasal spray antidepressant Spravato (esketamine), which ... of the drug as an add-on treatment for standard ...

Since October 2020 – when the Health Sciences Authority (HSA) first authorised sale of an esketamine nasal spray ... the ketamine nasal spray Spravato is now a mainstream prescription for ...

Since October 2020 – when the Health Sciences Authority (HSA) first authorised sale of an esketamine nasal spray ... the ketamine nasal spray Spravato is now a mainstream prescription for ...

Apimostinel has a similar mode of action to ketamine and derivatives like Johnson & Johnson's Spravato (esketamine) – approved by the FDA for treatment-resistant depression in 2019 and for MDD ...

Depending on your specific needs, Wave Treatment Centers offers a range of approaches from traditional medications to newer therapies such as transcranial magnetic stimulation (TMS). Additionally ...